v3.21.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Operating Expenses:        
Research and development expenses $ 2,319,049 $ 888,013 $ 4,370,672 $ 1,942,622
General and administrative expenses 2,084,676 930,779 4,873,387 2,176,415
Total Operating Expenses 4,403,725 1,818,792 9,244,059 4,119,037
Loss From Operations (4,403,725) (1,818,792) (9,244,059) (4,119,037)
Other Income (Expense)        
Interest income 1,181 5,182 1,476 28,614
Change in value of contingent liability (67,478) (61,203)
Other income 29,088 2,500 29,088 2,500
Total other income (expense) (37,209) 7,682 (30,639) 31,114
Loss Before Provision For Income Taxes (4,440,934) (1,811,110) (9,274,698) (4,087,923)
Provision for income taxes
Net Loss $ (4,440,934) $ (1,811,110) $ (9,274,698) $ (4,087,923)
Net loss per share, basic and diluted (in Dollars per share) $ (0.25) $ (0.16) $ (0.55) $ (0.38)
Weighted average shares, basic and diluted (in Shares) 17,588,840 11,292,037 16,854,425 10,894,681

Source